Oncotarget

VOLUME 4 (2013)

View Archive »

About The Cover

Visualizing Two-Compartment Tumor Metabolism, with Metabolic Marker Proteins: MCT4 and TOMM20. Human breast cancer samples (from primary tumors or lymph node metastases) were immuno-stained with antibodies directed against MCT4 (shown in RED) and TOMM20 (shown in BROWN). Image was digitaly enhanced for the cover of Oncotarget. See Sotgia et al.

Table of Contents

Editorial

https://doi.org/10.18632/oncotarget.1179

1117-1118
PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1183

1119-1120
PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1185

1121-1122
PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1196

1123-1124
PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1286

1125
PDF  |  Full Text  |  How to cite

Editorial Broadcast

https://doi.org/10.18632/oncotarget.1178

1126-1127
PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1244

1128-1129
PDF  |  Full Text  |  How to cite

Reviews

https://doi.org/10.18632/oncotarget.1181

1130-1142
Abstract  |  PDF  |  Full Text  |  How to cite

Research Papers

https://doi.org/10.18632/oncotarget.1084

1143-1148
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1074

1149-1157
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1093

1158-1171
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1126

1172-1184
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1162

1185-1198
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1122

1199-1211
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1130

1212-1229
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1145

1230-1240
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1147

1241-1252
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1141

1253-1265
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1164

1266-1279
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1176

1280-1292
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.1136

1293-1308
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Research Perspectives

https://doi.org/10.18632/oncotarget.1182

1309-1316
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.1170

1317-1328
Abstract  |  PDF  |  Full Text  |  How to cite


Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß